Session Type: ACR Poster Session C
Session Time: 9:00AM-11:00AM
Background/Purpose: To Compare the induction therapy of lupus nephritis with cyclophosphamide (CYC) high dose or low dose and identify possible predictors of disease remission.
|CYC HIGH DOSE GROUP||CYC LOW DOSE GROUP|
|Achieved Remission n(%)||26 (74%)||9 (45%)||p=0,03|
|Did not achieved remission n(%)||9 (26%)||11 (55%)|
Conclusion: The group of patients undergoing CYC high dose induction therapy achieved higher frequency of remission than the group with low dose of CYC after the induction therapy period. We did not found any predictor of renal remission.
To cite this abstract in AMA style:Valim J, Lima V, Guimarães F, Chaer F, Souza B. Comparison of Lupus Nephritis Induction Therapy with Cyclophosphamide High Dose Versus Low Dose [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/comparison-of-lupus-nephritis-induction-therapy-with-cyclophosphamide-high-dose-versus-low-dose/. Accessed October 28, 2020.
« Back to 2016 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-of-lupus-nephritis-induction-therapy-with-cyclophosphamide-high-dose-versus-low-dose/